Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.

MLA

Murdock, H.Moses, et al. “Impact of Diagnostic Genetics on Remission MRD and Transplantation Outcomes in Older Patients with AML.” Blood, vol. 139, no. 24, June 2022, pp. 3546–57. EBSCOhost, https://doi.org/10.1182/blood.2021014520.

APA

Murdock, H. M., Kim, H. T., Denlinger, N., Vachhani, P., Hambley, B., Manning, B. S., Gier, S., Cho, C., Tsai, H. K., McCurdy, S., Ho, V. T., Koreth, J., Soiffer, R. J., Ritz, J., Carroll, M. P., Vasu, S., Perales, M.-A., Wang, E. S., Gondek, L. P., … Gibson, C. J. (2022). Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML. Blood, 139(24), 3546–3557. https://doi.org/10.1182/blood.2021014520

Chicago

Murdock, H Moses, Haesook T Kim, Nathan Denlinger, Pankit Vachhani, Bryan Hambley, Bryan S Manning, Shannon Gier, et al. 2022. “Impact of Diagnostic Genetics on Remission MRD and Transplantation Outcomes in Older Patients with AML.” Blood 139 (24): 3546–57. doi:10.1182/blood.2021014520.